Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
AIDS Research and Human Retroviruses|July 2, 2005
Changes in nevirapine plasma concentrations over time and its relationship with liver enzyme elevationsDaniel González De Requena, Inmaculada Jiménez-Nácher, Vincent SorianoAIDS (London, England)|January 25, 2002
Liver toxicity caused by nevirapineDaniel González de Requena, Marina Núñez, Inmaculada Jiménez-Nácher, et al.AIDS (London, England)|December 4, 2004
Higher efavirenz concentrations determine the response to viruses carrying non-nucleoside reverse transcriptase resistance mutationsDaniel González de Requena, Oscar Gallego, Angélica Corral, et al.AIDS Research and Human Retroviruses|May 1, 2004
Prediction of virological response to lopinavir/ritonavir using the genotypic inhibitory quotientDaniel González de Requena, Oscar Gallego, Luisa Valer, et al.AIDS Research and Human Retroviruses|July 29, 2003
Indinavir plasma concentrations and resistance mutations in patients experiencing early virological failureDaniel González de Requena, Oscar Gallego, Carmen de Mendoza, et al.HIV Clinical Trials|December 26, 2002
Does an increase in nevirapine plasma levels cause complete virologic suppression in patients experiencing early virologic failure?Daniel González de Requena, Marina Núñez, Oscar Gallego, et al.AIDS Patient Care and Stds|November 1, 2003
Correlation between lopinavir plasma levels and lipid abnormalities in patients taking lopinavir/ritonavirDaniel González de Requena, Francisco Blanco, Teresa Garcia-Benayas, et al.AIDS Patient Care and Stds|March 10, 2004
Impact of drug levels and baseline genotype and phenotype on the virologic response to amprenavir/ritonavir-based salvage regimensLuisa Valer, Daniel González de Requena, Carmen de Mendoza, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2004
Analyzing sleep abnormalities in HIV-infected patients treated with EfavirenzLucía Gallego, Pablo Barreiro, Rafael del Río, et al.AIDS (London, England)|September 22, 2006
Unexpected drug-drug interaction between tipranavir/ritonavir and enfuvirtideDaniel González de Requena, Andrea Calcagno, Stefano Bonora, et al.Pageof 1